4D Path

Last updated: October 11, 2024

Founder Rodrigo Navarro
Founder Rodrigo Navarro
USA | Funding: $18.8M (+)

Website: https://www.4dpath.com/

4D Path uses H&E biopsy images to unveil hidden data instantly providing biomarker profiling and stratification. Although their initial focus is on breast cancer, the company is actively working on developing products for ovarian cancer, cervical cytology, skin cancer, and, in general, around immunotherapy in various cancers.